Drug Approval | October 31, 2025
The facility has been classified as Voluntary Action Indicated
Sun Pharma's Halol plant gets OAI classification from US FDA inspection
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
The USFDA has determined the inspection classification status of this warehousing facility as 'Official Action Indicated
Indoco is comprehensively working on the remedial action plan
HSGP is engaged closely with the USFDA and is committed to address the OAI observations through planned remediation measures
Sun Pharma's Dadra facility receives OAI status from US FDA
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
Subscribe To Our Newsletter & Stay Updated
